These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16915233)

  • 1. Can open-source R&D reinvigorate drug research?
    Munos B
    Nat Rev Drug Discov; 2006 Sep; 5(9):723-9. PubMed ID: 16915233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in development and approval times for new therapeutics in the United States.
    Reichert JM
    Nat Rev Drug Discov; 2003 Sep; 2(9):695-702. PubMed ID: 12951576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The state of innovation in drug development.
    Kola I
    Clin Pharmacol Ther; 2008 Feb; 83(2):227-30. PubMed ID: 18202690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in antimicrobial drug development: implications for the future.
    Spellberg B; Powers JH; Brass EP; Miller LG; Edwards JE
    Clin Infect Dis; 2004 May; 38(9):1279-86. PubMed ID: 15127341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The critical path to medical innovation.
    Williams D
    Med Device Technol; 2004 Jun; 15(5):8-10. PubMed ID: 15285478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in standards for reporting omics data.
    Taylor CF
    Curr Opin Drug Discov Devel; 2007 May; 10(3):254-63. PubMed ID: 17554851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carlo Incerti.
    Incerti C
    Nat Rev Drug Discov; 2008 Aug; 7(8):638. PubMed ID: 18670428
    [No Abstract]   [Full Text] [Related]  

  • 8. In search of sustainability: process R&D in light of current pharmaceutical industry challenges.
    Federsel HJ
    Drug Discov Today; 2006 Nov; 11(21-22):966-74. PubMed ID: 17055405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promoting, improving and accelerating the drug development and approval processes.
    Graul AI
    Drug News Perspect; 2009; 22(1):30-8. PubMed ID: 19209297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefit the patient, manage the risk: a system goal.
    Califf RM
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):269-76. PubMed ID: 15133777
    [No Abstract]   [Full Text] [Related]  

  • 11. Are the economics of pharmaceutical research and development changing?: productivity, patents and political pressures.
    Grabowski H
    Pharmacoeconomics; 2004; 22(2 Suppl 2):15-24. PubMed ID: 15660474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual drug discovery and development for neglected diseases through public-private partnerships.
    Nwaka S; Ridley RG
    Nat Rev Drug Discov; 2003 Nov; 2(11):919-28. PubMed ID: 14668812
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug development--from receptor research to therapy].
    Lammintausta R; Scheinin M
    Duodecim; 1998; 114(10):957-66. PubMed ID: 11524784
    [No Abstract]   [Full Text] [Related]  

  • 14. Helping science to succeed: improving processes in R&D.
    Sewing A; Winchester T; Carnell P; Hampton D; Keighley W
    Drug Discov Today; 2008 Mar; 13(5-6):227-33. PubMed ID: 18342798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competitive Workflow: novel software architecture for automating drug design.
    Cartmell J; Krstajic D; Leahy DE
    Curr Opin Drug Discov Devel; 2007 May; 10(3):347-52. PubMed ID: 17554862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pivotal role of drug metabolism and pharmacokinetics in the discovery and development of new medicines.
    Alavijeh MS; Palmer AM
    IDrugs; 2004 Aug; 7(8):755-63. PubMed ID: 15334309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growing pains in AIDS drug development.
    Herrera S
    Nat Biotechnol; 2004 Oct; 22(10):1194. PubMed ID: 15470440
    [No Abstract]   [Full Text] [Related]  

  • 18. Ligand-based vascular targeting of disease.
    Rybak JN; Trachsel E; Scheuermann J; Neri D
    ChemMedChem; 2007 Jan; 2(1):22-40. PubMed ID: 17154429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identifying quality leads - an important factor in reducing attrition of clinical candidates.
    Chackalamannil S; Desai MC
    Curr Opin Drug Discov Devel; 2007 Jul; 10(4):381-2. PubMed ID: 17659478
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.